Diabetes Research and Clinical Practice
Volume 78, Issue 3, Supplement , Pages S47-S50 , 20 December 2007

Achieving normoglycemia in hospitalized patients

  • Aleksandra Szymborska-Kajanek

      Affiliations

    • Department of Internal Diseases, Diabetology and Nephrology, 3-Maja Street 13/15, 41-800 Zabrze, Poland
  • ,
  • Krystyn Sosada

      Affiliations

    • Department of General and Bariatric Surgery, Silesian Medical University, Zabrze, Poland
  • ,
  • Krzysztof Strojek

      Affiliations

    • Department of Internal Diseases, Diabetology and Nephrology, 3-Maja Street 13/15, 41-800 Zabrze, Poland
    • Corresponding Author InformationCorresponding author. Tel.: +48 32 2712511; fax: +48 32 2714617.

References 

  1. Roper NA, Bilous RW, Kelly WF, Unwin NC, Connolly VM. Excess mortality in a population with diabetes and the impact of material deprivation: longitudinal, population based study. BMJ. 2001;322:1375–1376
  2. Mizock BA. Alterations in fuel metabolism in critical illness: hyperglycaemia. Best Pract. Res. Clin. Endocrinol. Metab. 2001;15:533–551
  3. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al. Intensive insulin therapy in the critically ill patients. N. Engl. J. Med. 2001;345:1359–1367
  4. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, et al. Intensive insulin therapy in the medical ICU. N. Engl. J. Med. 2006;354:449–461
  5. Van den Berghe G. How does blood glucose control with insulin save lives in intensive care?. J. Clin. Invest. 2004;114:1187–1195
  6. Ellger B, Debaveye Y, Vanhorebeek L, Langouche I, Langouche L, Giulietti A, et al. Survival benefits of intensive insulin therapy in critical illness: impact of maintaining normoglycemia versus glycemia-independent actions of insulin. Diabetes. 2006;55:1096–1105
  7. Malmberg K. Prospective randomized study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. BMJ. 1997;314:1512–1515
  8. Malmberg K, Ryden L, Wedel H, Birkeland K, Bootsma A, Dickstein K, et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur. Heart. J. 2005;26:650–651
  9. The DECODE study group on behalf of the European Diabetes Epidemiology Group, Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria, Lancet 354 (1999) 617–621.
  10. Milicevic Z, Raz I, Strojek K, Skrha J, Tan MH, Watt JW, et al. Hyperglycemia and its effect after acute myocardial infarction on cardiovascular outcomes in patients with Type 2 diabetes mellitus (HEART2D). J. Diabetes Complications. 2005;19:80–87
  11. Milicevic Z, Raz I, Beattie S, Sarwat S, Bozikov V, Strojek K, et al. Hyperglycemia and its effect after acute myocardial infarction on cardiovascular outcomes in patients with type 2 diabetes mellitus (HEART2D): characteristics of the patient population as baseline. Diabetologia. 2006;49(Suppl. 1):
  12. Furnary AP, Gao G, Grunkemeier GL, Wu Y, Zerr KJ, Bookin SO, et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J. Thorac. Cardiovasc. Surg. 2003;125:1007–1021
  13. Goldberg PA, Siegel MD, Sherwin RS, Halickman JI, Lee M, Bailey VA, et al. Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit. Diabetes Care. 2004;27:461–467
  14. Krinsley JS, Jones RL. Cost analysis of intensive glycemic control in critically ill adult patients. Chest. 2006;129(129):644–650
  15. de Block C, Manuel-Y-Keenoy B, Van Gaal L, Rogiers P. Intensive insulin therapy in the intensive care unit: assessment by continuous glucose monitoring. Diabetes Care. 2006;29:1750–1756

PII: S0168-8227(07)00505-0

doi: 10.1016/j.diabres.2007.09.024

Diabetes Research and Clinical Practice
Volume 78, Issue 3, Supplement , Pages S47-S50 , 20 December 2007